Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$109.94 USD
+0.67 (0.61%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $109.98 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: AMC |
3/2024 | $4.15 | -2.09% |
Earnings Summary
For their last quarter, Jazz Pharmaceuticals (JAZZ) reported earnings of $5.02 per share, missing the Zacks Consensus Estimate of $5.26 per share. This reflects a negative earnings surprise of 4.56%. Look out for JAZZ's next earnings release on May 01, 2024. For the next earning release, we expect the company to report earnings of $4.15 per share, reflecting a year-over-year increase of 5.06%.
Earnings History
Price & Consensus
Zacks News for JAZZ
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services